pregnancy and glp 1 GLP-1 use during early may not increase risk of major adverse outcomes A new study found reassuring

Research demonstrates it upregulates growth hormone receptors locally, promotes angiogenesis through VEGF pathways, and modulates nitric oxide synthesis to accelerate tissue vascularization

A well-designed recomposition protocol achieves what most patients find difficult through diet and training alone: meaningful changes in both body fat percentage and lean mass simultaneously

The Link Between Semaglutide and Menstrual Irregularities Semaglutide, primarily used to manage diabetes and weight, impacts the body in multiple ways

By 2030, approximately 30.3 million people in the U.S

GLP-1 drugs are primarily recommended for: Adults with type 2 diabetes who arent seeing results from oral medications and need better blood sugar control People with obesity or with a BMI over 30 (with or without diabetes) seeking medical weight management Doctors may also consider GLP-1 RAs for patients with cardiovascular risk factors, as some of these drugs have shown heart-protective benefits